Furthermore, chronic hyperglycemia, as seen in diabetic nephropathy, drives advanced glycation end-products (AGEs) formation and PKC activation, which alter nephrin and podocin expression through transcriptional repression and post-translational modifications. The gene discussed is PRRT2; the disease is diabetic kidney disease.